Magnetic resonance imaging and proton magnetic resonance spectroscopy in neuro-Behçet's disease

Clinical and Experimental Rheumatology

Volumn 22, Issue 5, 2004, Pages 561-567

  Park, Kyung Su ^a   Ko, Hyeok Jae ^a   Yoon, C H ^a   Park, Sung Hwan ^a   Cho, Chul Soo ^a   Kim, Ho Youn ^a   Choe, Bo Young ^a   Kim, Wan Uk ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Magnetic resonance imaging; Magnetic resonance spectroscopy; Neuro Beh et's disease

Indexed keywords

ANALGESIC AGENT; AZATHIOPRINE; BROMOCRIPTINE; CHLORAMBUCIL; CREATINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; N ACETYLASPARTIC ACID; PREDNISOLONE; PROPRANOLOL; TRIHEXYPHENIDYL;

ADULT; ARTICLE; BASAL GANGLION; BEHCET DISEASE; BLOOD LEVEL; BRAIN INJURY; BRAIN REGION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ETHNOLOGY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; KOREA; MALE; MEASUREMENT; MESENCEPHALON; NEUROLOGIC DISEASE; NORMAL VALUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PONS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; THALAMUS; TIME; TREATMENT OUTCOME; WHITE MATTER;

ADULT; AGED; BEHCET SYNDROME; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KOREA; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREDNISOLONE; SENSITIVITY AND SPECIFICITY;

EID: 4644371181     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. International Study Group For Behçet's Disease: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
2. O'DUFFY JD, GOLDSTEIN NP: Neurologic involvement in seven patients with Behçet's disease. Am J Med 1976; 61: 170-8.
3. SERDAROGLU P, YAZICI H, ÖZDEMIR C, YURDAKUL S, BAHAR S, AKTIN E: Neurologic involvement in Behçet's syndrome. Arch Neurol 1989; 46: 265-9.
4. AKMAN-DEMIR G, SERDAROGLU P, TASCI B et al.: Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain 1999; 122: 2171-81.
5. KIDD D, STEUER A, DENMAN AM, RUDGE P: Neurological complications in Behçet's syndrome. Brain 1999; 122: 2183-94.
6. Al KAWI MZ, BOHLEGA S, BANNA M: MRI findings in neuro-Behçet's disease. Neurology 1991; 41: 405-8.
7. TALI ET, ATILLA A, KESKIN T et al.: MRI in neuro-Behçet's disease. Neuroradiology 1997; 39: 2-6.
8. WECHSLER B, DELL'ISOLA B, VIDAIHET M et al.: MRI in 31 patients with Behçet's disease and neurological involvement: prospective study with clinical correlation. J Neurol Neurosurg Psychiatry 1993; 56: 793-8.
9. MARKUS HS, BUNKER CB, KOURIS K, COSTA DC, HARRISON MJ: rCBF abnormalities detected, and sequentially followed, by SPECT in neuro-Behcet's syndrome with normal CT and MRI imaging. J Neurol 1992; 239: 363-6.
10. SIBBITT WL Jr, SIBBITT RR: Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 1993; 19: 851-67.
11. HENRIKSEN O: MR spectroscopy in clinical research. Acta Radiologica 1994; 35: 96-116.
12. CHINN RJS, WILKINSON ID, HALL-GRAGGS MA et al.: Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 36-46.
13. LIM MK, SUH CH, KIM HJ et al.: Systemic lupus erythematosus: Brain MR imaging and single-voxel hydrogen 1 MR spectroscopy. Radiology 2000; 217: 43-9.
14. 1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia. Acad Radiol 1994; 1: 211-6.
15. SIBBITT WL Jr, HASELER LJ, GRIFFEY RH, HART BL, SIBBITT RR, MATWIYOFF NA: Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy. AJNR Am J Neuroradiol 1994; 15: 923-8.
16. SERDAROGLU P: Behçet's disease and the nervous system. J Neurol 1998; 245: 197-205.
17. RIZZI R, BRUNO S, DAMMACCO R: Behçet's disease: an immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 1997; 27: 225-32.
18. EHRLICH GE: Vasculitis in Behçet's disease. Int Rev Immunol 1997; 14: 81-8.
19. O'DUFFY JD: Vasculitis in Behçet's disease. Rheum Dis Clin North Am 1990; 16: 423-31.
20. ISEKI E, IWABUCHI K, YAGISHITA S, AMANO N, MATSUSHITA M: Two necropsy cases of chronic encephalomyelitis: variants of Neuro- Behçet's syndrome ? J Neurol Neurosurg Psychiatry 1988; 51: 1084-7.
21. BESANA C, COMI G, Del MASCHIO A et al.: Electrophysiological and MRI evaluation of neurological involvement in Behçet's disease. J Neurol Neurosurg Psychiatry 1989; 52: 749-54.
22. KAO CH, LAN JL, CHANGLAI SP, CHIENG PU: Technetium-99m-HMPAO SPECT and MRI of brain in patients with neuro-Behçet's syndrome. J Nucl Med 1998; 39: 1707-10.
23. NÜSSEL F, WEGMÜLLER H, LASEYRAS F, POSSE S, HERSCHKOWITZ N, HUBER P: Neuro-Behçet's disease: Acute and sequential aspects by MRI and MRS. Eur Neurol 1991; 31: 399-402.
24. OTTE A, WEINER SM, HOEGERLE S et al.: Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study. Lupus 1998; 7: 57-9.